
Arm CEO: AI Will Cure Cancer
Artificial intelligence will help cure cancer within our lifetimes, according to Rene Haas, chief executive of Arm, the Cambridge-based company whose chip designs sit inside almost every smartphone on Earth. There are more than 350 billion chips using Arm technology have shipped worldwide. Haas says health is the "killer app" for the technology. Drugs can take 20 years to develop and around 95% of research and development efforts fail. He argues AI will shorten both the time it takes to discover new drugs and the time needed to test them, with some human trials eventually supplemented or replaced by AI modelling. "I believe in our lifetime, AI will help cure cancer," he tells BBC Economics editor Faisal Islam. But the ambitions Haas describes run into a physical constraint: the world cannot manufacture enough chips to meet demand. He says the industry is in an "absolutely supply-constrained environment" and expects that pressure to continue. Memory chip prices have risen sharply, smartphones are becoming more expensive, and handset demand is under pressure. Asked whether the shortage is simply a temporary bump, he says: "If it's a bump, it's a really, really big bump." The expansion of AI infrastructure is driving much of that demand. Large AI models require vast amounts of memory and computing power, while technology companies are committing hundreds of billions of dollars to new data centres.
Publisher
Big Boss Interview
Link
www.bbc.co.uk/programmes/p0p8dw42
Published
September 7, 2026
Duration
39 min
Format
Podcast
Category
News · Business News
Source
RSS feed
Host
BBC News
Big Boss Interview
@bigbossinterview
#armceo #curecancer
